DocGo (DCGO) Common Equity (2020 - 2026)

DocGo's Common Equity history runs 7 years deep, the most recent figure standing at $132.3 million for Q1 2026.

• In Q1 2026, Common Equity fell 56.18% year-over-year to $132.3 million; the TTM figure through Mar 2026 stood at $132.3 million (down 56.18% YoY), while the FY2025 annual figure was $125.9 million, down 60.06% from the prior year.
• Common Equity for Q1 2026 stood at $132.3 million, up from $125.9 million in the prior quarter.
• The five-year high for Common Equity was $324.9 million in Q3 2024, with the low at $125.9 million in Q4 2025.
• The 5-year median for Common Equity is $283.9 million (2023), against an average of $270.0 million.
• The sharpest annual moves came in 2022 and 2025: Common Equity surged 303.84% in 2022, then tumbled 60.06% in 2025.
• DocGo's Common Equity stood at $278.9 million in 2022, then rose by 9.41% to $305.2 million in 2023, then increased by 3.28% to $315.2 million in 2024, then slumped by 60.06% to $125.9 million in 2025, then rose by 5.12% to $132.3 million in 2026.
• Business Quant data shows DCGO's Common Equity at $132.3 million in Q1 2026, $125.9 million in Q4 2025, and $260.7 million in Q3 2025.